Conversion from twice-daily (Prograf®) to once-daily (Advagraf®) tacrolimus formulation in stable pediatric kidney transplant recipients: a comparative pharmacokinetic study

被引：0
|
作者：
Anne-Laure, Lapeyraque [1 ]
Nastya, Kassir
Marie-Jose, Clermont [1 ]
Maja, Krajinovic [1 ]
Yves, Theoret [1 ]
Catherine, Litalien [1 ]
Phan Veronique [1 ]
机构：
[1] Univ Montreal, CHU St Justine, Montreal, PQ H3C 3J7, Canada
来源：
PEDIATRIC NEPHROLOGY | 2012年 / 27卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1634 / 1634
页数：1
相关论文
共 50 条
  • [41] Conversion From Twice-daily To Once-daily Tacrolimus In Pediatric Kidney Transplant Recipients: What Do The Patients Think About It?
    Favennec, Caroline
    Kessler, Gwenaelle Roussey
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1756 - 1756
  • [42] CONVERSION OF TWICE-DAILY PROGRAF TO ONCE-DAILY ADVAGRAF LOWERED WITHIN-PATIENT VARIABILITY OF BLOOD TACROLIMUS CONCENTRATION
    Han, Sang Youb
    Roh, Young Nam
    Jang, Hye Yeon
    Jun, Heung Man
    TRANSPLANT INTERNATIONAL, 2017, 30 : 509 - 510
  • [43] The association between trough blood concentration and systemic exposure of tacrolimus: Comparison between once-daily (Advagraf®) and twice-daily (Prograf®) formulation in de novo kidney transplant recipients
    Sukkha, Sayamon
    Chindavijak, Busba
    Nosoongnoen, Wichit
    Phakdeekitchareon, Bunyong
    Kitiyakara, Chagriya
    Sumethkul, Vasant
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : 139 - 144
  • [44] Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study
    Lapeyraque, Anne-Laure
    Kassir, Nastya
    Theoret, Yves
    Krajinovic, Maja
    Clermont, Marie-Jose
    Litalien, Catherine
    Phan, Veronique
    PEDIATRIC NEPHROLOGY, 2014, 29 (06) : 1081 - 1088
  • [45] Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study
    Anne-Laure Lapeyraque
    Nastya Kassir
    Yves Théorêt
    Maja Krajinovic
    Marie-José Clermont
    Catherine Litalien
    Véronique Phan
    Pediatric Nephrology, 2014, 29 : 1081 - 1088
  • [46] Once-Daily Prolonged-Release Tacrolimus (ADVAGRAF) Versus Twice-Daily Tacrolimus (PROGRAF) in Liver Transplantation
    Trunecka, P.
    Boillot, O.
    Seehofer, D.
    Pinna, A. D.
    Fischer, L.
    Ericzon, B-G
    Trois, R. I.
    Baccarani, U.
    Ortiz de Urbina, J.
    Wall, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (10) : 2313 - 2323
  • [47] Pharmacokinetic Profile of Twice- and Once-daily Tacrolimus in Pediatric Kidney Transplant Recipients
    Takahashi, Y.
    Shishido, S.
    Hyodo, Y.
    Yonekura, T.
    Nihei, H.
    Itabashi, Y.
    Muramatsu, M.
    Hamasaki, Y.
    Kawamura, T.
    Aikawa, A.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (01) : 37 - 40
  • [48] Conversion of stable pediatric liver transplant recipients from twice daily prograf to once daily modified release tacrolimus.
    Heffron, TG
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 511 - 511
  • [49] A Switch From Conventional Twice-Daily Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Kidney Transplant Recipients
    Hatakeyama, S.
    Fujita, T.
    Yoneyama, T.
    Yoneyama, T.
    Koie, T.
    Hashimoto, Y.
    Saitoh, H.
    Funyu, T.
    Narumi, S.
    Ohyama, C.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (01) : 121 - 123
  • [50] EFFECT OF CONVERSION FROM TWICE-DAILY TO ONCE-DAILY TACROLIMUS ON GLUCOSE INTOLERANCE IN STABLE KIDNEY TRANSPLANT RECIPIENTS - EVALUATION AT 12 MONTHS
    Ito, Shinichi
    Tsuchiya, Tomohiro
    Nagai, Shingo
    Deguchi, Takashi
    TRANSPLANT INTERNATIONAL, 2013, 26 : 90 - 90
12345